Dr Raza Hussain, MD | |
1 Medical Park Blvd, Bristol, TN 37620-7430 | |
(423) 844-1121 | |
Not Available |
Full Name | Dr Raza Hussain |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 1 Medical Park Blvd, Bristol, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265099923 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 0000065482 (Tennessee) | Primary |
Entity Name | Southeastern Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083835441 PECOS PAC ID: 0042307852 Enrollment ID: O20071025000571 |
News Archive
ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.
From the food we eat to the products we use, there are a lot of misconceptions about what may increase the risk of developing breast cancer. There are known factors, like genetics, that are well documented. But what about lifestyle issues like having a nightly cocktail or using deodorant? So, what is fact and what is fiction? Wendy Chen, MD, MPH, a breast cancer expert at Dana-Farber Cancer Institute in Boston says an overabundance of information can be confusing, and it often is incorrect to some degree.
A new, enhanced-potency onoclonal antibody designed to keep the sniffles from turning into a devasting illness in at-risk babies is under study at the Medical College of Georgia Children's Medical Center.
A Johns Hopkins review of nearly 150 randomized controlled trials on children - all published in well-regarded medical journals - reveals that 40 to 60 percent of the studies either failed to take steps to minimize risk for bias or to at least properly describe those measures.
Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Raza Hussain, MD Po Box 70622, Johnson City, TN 37614-1709 Ph: (423) 439-6282 | Dr Raza Hussain, MD 1 Medical Park Blvd, Bristol, TN 37620-7430 Ph: (423) 844-1121 |
News Archive
ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.
From the food we eat to the products we use, there are a lot of misconceptions about what may increase the risk of developing breast cancer. There are known factors, like genetics, that are well documented. But what about lifestyle issues like having a nightly cocktail or using deodorant? So, what is fact and what is fiction? Wendy Chen, MD, MPH, a breast cancer expert at Dana-Farber Cancer Institute in Boston says an overabundance of information can be confusing, and it often is incorrect to some degree.
A new, enhanced-potency onoclonal antibody designed to keep the sniffles from turning into a devasting illness in at-risk babies is under study at the Medical College of Georgia Children's Medical Center.
A Johns Hopkins review of nearly 150 randomized controlled trials on children - all published in well-regarded medical journals - reveals that 40 to 60 percent of the studies either failed to take steps to minimize risk for bias or to at least properly describe those measures.
Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects.
› Verified 2 days ago
Dr. Nafees Ameer Mohammed, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 271 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-4800 Fax: 423-230-6905 | |
Rick Whiles, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Medical Park Blvd, Ste 3600, Bristol, TN 37620 Phone: 423-990-2414 | |
Dr. Jean Marie Mancini, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Ste 450w, Bristol, TN 37620 Phone: 423-968-3713 Fax: 423-986-7352 | |
Dr. Craig S Graul, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 Manchester Pl, Bristol, TN 37620 Phone: 423-573-1988 | |
Roger J Mcsharry, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 271 Medical Park Blvd, Bristol, TN 37620 Phone: 423-968-2311 Fax: 423-968-2311 | |
Steven Michael Tomski, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Medical Park Blvd Ste 2000, Bristol, TN 37620 Phone: 423-990-5495 Fax: 423-990-2492 | |
Theodore Thompson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 Volunteer Pkwy, Bristol, TN 37620 Phone: 423-274-6610 Fax: 423-274-6619 |